- Additional Proxy Soliciting Materials (definitive) (DEFA14A)
June 05 2009 - 2:14PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC. 20549
SCHEDULE
14A
(Rule
14A-101)
INFORMATION
REQUIRED IN PROXY STATEMENT
SCHEDULE
14A INFORMATION
Proxy
Statement Pursuant to Section 14(a) of
the
Securities Exchange Act of 1934
Filed by the Registrant
x
Filed by a Party other than the Registrant
Check the
appropriate box:
o
|
|
Preliminary Proxy Statement
|
o
|
|
Confidential, for Use of the
Commission Only
|
o
|
|
Definitive Proxy Statement
|
|
|
(as
permitted by Rule 14a-6(e)(2))
|
x
|
|
Definitive Additional
Materials
|
|
|
|
o
|
|
Soliciting Material Pursuant to
Rule 14a-11(c)
or Rule 14a-12
|
|
|
|
LEXICON
PHARMACEUTICALS, INC.
|
(
Name
o
f
Registrant
as
Specified
In Its Charter)
|
|
(Name of
Person(s) Filing Proxy Statement, if Other Than the
Registrant)
|
Payment of
Filing Fee (Check the appropriate box):
o
|
Fee
computed
on
table
below per Exchange Act
Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title
of each class of securities to which transaction
applies: N/A
|
|
(2)
|
Aggregate
number of securities to which transaction
applies: N/A
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was
determined): N/A
|
|
(4)
|
Proposed
maximum aggregate value of transaction: N/A
|
|
(5)
|
Total
fee paid: $0
|
o
|
Fee paid previously with
preliminary materials: N/A
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
(1)
|
Amount
Previously Paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
(3)
|
Filing Party:
|
|
(4)
|
Date
Filed
|
***
Exercise Your
Right
to Vote ***
|
IMPORTANT
NOTICE
Regarding the Availability of Proxy
Materials
|
|
|
|
|
|
|
|
|
Meeting
Information
|
|
|
|
|
|
|
|
|
Meeting
Type:
|
Special
Meeting
|
|
|
|
For holders
as of:
|
May 21,
2009
|
LEXICON
PHARMACEUTICALS, INC.
|
|
Date:
|
July 15,
2009
|
|
|
|
Time:
|
1:30 PM
LST
|
|
|
|
Location:
|
Lexicon
Pharmaceuticals, Inc.
|
|
|
|
|
8800
Technology Forest Place
|
|
|
|
|
The
Woodlands, Texas
|
|
|
|
|
|
|
|
|
|
|
|
|
|
You are
receiving this communication because you hold shares in the above named
company.
|
|
|
|
|
|
LEXICON
PHARMACEUTICALS, INC.
8800
TECHNOLOGY FOREST PLACE
THE
WOODLANDS, TX 77381
|
|
|
This is not a
ballot. You cannot use this notice to vote these shares. This
communication presents only an overview of the more complete proxy
materials that are available to you on the Internet. You may view
the proxy materials online at www.proxyvote.com or easily request a paper
copy (see reverse side).
|
|
|
|
|
|
|
|
|
We encourage
you to access and review all of the important information contained in the
proxy materials before voting.
|
|
|
|
|
|
|
|
|
See the
reverse side of this notice to obtain proxy materials and voting
instructions.
|
|
*** Before
You Vote ***
|
|
|
How to Access the Proxy
Materials
|
|
|
|
|
|
|
|
|
|
Proxy
Materials Available to VIEW or RECEIVE:
|
|
|
|
|
1.
Notice &
Proxy
Statement
|
|
|
|
|
|
How
to View Online:
|
|
|
|
|
|
Have the
12-Digit Control Number available (located on the following page) and
visit
www.proxyvote.com
|
|
|
|
How
to Request and Receive a PAPER or E-MAIL Copy:
|
|
|
|
|
If you want
to receive a paper or email copy of these documents, you must request
one. There is NO charge for requesting a copy. Please choose
one of the following methods to make your request:
|
|
|
|
1) BY
INTERNET:
|
www.proxyvote.com
|
|
|
|
|
|
2) BY
TELEPHONE:
|
1-800-579-1639
|
|
|
|
|
|
3) BY
E-MAIL*:
|
sendmaterial@proxyvote.com
|
|
|
|
|
|
|
|
|
|
|
|
*
If requesting materials by e-mail, please send a blank email with the
12-Digit Control Number (located on the following page) in the subject
line
|
|
|
|
|
|
|
|
|
|
Requests,
instructions and other inquiries sent to this e-mail address will NOT be
forwarded to your investment advisor. Please make the request as
instructed above on or before July 01, 2009 to facilitate timely
delivery.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*** How
to Vote ***
|
|
|
Please Choose One of the Following Voting
Methods
|
|
|
|
|
|
|
|
|
|
Vote In Person:
Many shareholder
meetings have attendance requirements including, but not limited to, the
possession of an attendance ticket issued by the entity holding the
meeting. Please check the meeting materials for any special
requirements for meeting attendance. At the Meeting you will need to
request a ballot to vote these shares.
|
|
|
|
|
|
|
|
|
|
Vote by Internet:
To vote now by
Internet, go to www.proxyvote.com. Have the 12 Digit Control Number
available and follow the instructions.
|
|
|
|
|
|
|
|
|
|
Vote by Mail:
You can vote by mail
by requesting a paper copy of the materials, which will include a proxy
card.
|
|
|
|
|
|
|
|
|
The
Board of Directors recommends you vote FOR the following
proposal(s)
1.
|
Approval of an
amendment to the Company's certificate of incorporation increasing the
number of authorized shares of the Company's common stock from 300,000,000
to 900,000,000.
|
NOTE:
In their descretion, upon such other
business that may properly come before the meeting or any adjournment or
adjournments thereof.
The shares
represented by this proxy, when properly executed, will be voted in the manner
directed herein by the undersigned Stockholder(s). If no direction is
made, this proxy will be voted FOR item 1. If any other matters
properly come before the meeting, or if cumulative voting is required, the
person named in this proxy will vote in their
discretion.
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jul 2023 to Jul 2024